Detection of Promoter DNA Methylation of APC, DAPK, and GSTP1 Genes in tissue Biopsy and Matched Serum of Advanced-Stage Lung Cancer Patients

References

• Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability adjusted life-years for 32 cancer groups, 1990 to 2015 – a systematic analysis for the global burden of disease study. JAMA Oncol 2016 [Epub ahead of print]. doi:10.1001/jamaoncol.2016.5688
   Web of Science ®Google Scholar
• Ramalingam SS, Owonikoko TK, Khuri FR. Lung cancer: new biological insights and recent therapeutic advances. CA Cancer J Clin 2011;61:91–112.
   PubMed Web of Science ®Google Scholar
• Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol 2011;12:175–180.
   PubMed Web of Science ®Google Scholar
• Korpanty GJ, Graham DM, Vincent MD, Leighl NB. Biomarkers that currently affect clinical practices in lung cancer: EGFR, ALK, MET, ROS-1, and KRAS. Front Oncol 2014;4:204.
   PubMedGoogle Scholar
• Belinsky SA. Unmasking the lung cancer epigenome. Annu Rev Physiol 2015;77:453–474.
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042–2054.
   PubMed Web of Science ®Google Scholar
• Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 1999;59:67–70.
   PubMed Web of Science ®Google Scholar
• Pathak AK, Bhutani M, Kumar S, Mohan A, Guleria R. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 2006;52:1833–1842.
   PubMed Web of Science ®Google Scholar
• Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC. Plasma DNA level in predicting therapeutic efficacy in advanced non-small cell lung cancer. Eur Respir J 2010a;36:885–892.
   PubMed Web of Science ®Google Scholar
• Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC. Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy. Lung Cancer 2010b;70:211–217.
   PubMed Web of Science ®Google Scholar
• Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidransky D, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004;10:2284–2288.
   PubMed Web of Science ®Google Scholar
• Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, et al. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 2004;22:2363–2370.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lan Q, Shen M, Jin J, Mumford J, Ren D, et al. Aberrant gene promoter methylation in sputum from individuals exposed to smoky coal emissions. Anticancer Res 2008;28:2061–2066.
   PubMed Web of Science ®Google Scholar
• Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, et al. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Carcinogenesis 2008;29:1845–1849.
   PubMed Web of Science ®Google Scholar
• Moyer AM, Salavaggione OE, Wu TY, Moon I, Eckloff BW, Hildebrandt MA, et al. Glutathione S-transferase P1: gene sequence variation and functional genomic studies. Cancer Res 2008;68:4791–5001.
   PubMed Web of Science ®Google Scholar
• Cohen O, Feinstein E, Kimchi A. DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J 1997;16:998–1008.
   PubMed Web of Science ®Google Scholar
• Cohen O, Inbal B, Kissil JL, Raveh T, Berissi H, Spivak-Kroizaman T, et al. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain. J Cell Biol 1999;146:141–148.
   PubMed Web of Science ®Google Scholar
• Lesko AC, Goss KH, Prosperi JR. Exploiting APC function as a novel cancer therapy. Curr Drug Targets 2014;15:90–102.
   PubMed Web of Science ®Google Scholar
• Aoki K, Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci 2007;120 (Pt 19):3327–3335.
   PubMed Web of Science ®Google Scholar
• Mountain CF. Revision in the international system for staging lung cancer. Chest 1997;111:1710–1717.
   PubMed Web of Science ®Google Scholar
• Gajalakshmi V, Hung RJ, Mathew A, Varghese C, Brennan P, Boffetta P. Tobacco smoking and chewing, alcohol drinking and lung cancer risk among men in Southern India. Int J Cancer 2003;107:441–447.
   PubMed Web of Science ®Google Scholar
• Gao L, Xie E, Yu T, Chen D, Zhang L, Zhang B, et al. Methylated APC and RASSF1A in multiple specimens contribute to the differential diagnosis of patients with undetermined solitary pulmonary nodules. J Thorac Dis 2015;7:422–432.
   PubMed Web of Science ®Google Scholar
• Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, et al. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 2011;17:4494–4503.
   PubMed Web of Science ®Google Scholar
• Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371–375.
   PubMed Web of Science ®Google Scholar
• Sheikhnejad R, Zohri M, Shadmehr MB, Rahmani-Khalili M, Doozande N, Farsad Z, et al. Detection of aberrant methylation of 10 genes in genomic DNA of lung tumors. Ann Oncol 2013;24:2705–2706.
   PubMed Web of Science ®Google Scholar
• Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001;20:3528–3532.
   PubMed Web of Science ®Google Scholar
• Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y, Motoyama T. Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci 2003;94:589–592.
   PubMed Web of Science ®Google Scholar
• Shivapurkar N, Stastny V, Suzuki M, Wistuba II, Li L, Zheng Y, et al. Application of a methylation gene panel by quantitative PCR for lung cancers. Cancer Lett 2007;247:56–71.
   PubMed Web of Science ®Google Scholar
• Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, et al. DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2008;17:645–654.
   PubMed Web of Science ®Google Scholar
• Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, et al. Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 2005;11:2466–2470.
   PubMed Web of Science ®Google Scholar
• Niklinska W, Naumnik W, Sulewska A, Kozłowski M, Pankiewicz W, Milewski R. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). Folia Histochem Cytobiol 2009;47:275–280.
   PubMed Web of Science ®Google Scholar
• Zheng S, Jiang D, Ge J. The promoter hypermethylation of DAPK gene and p16 gene in non-small cell lung cancer patients. In: Shi R, Fu W, Wang Y, Wang H, editors. 2nd International Conference on Biomedical Engineering and Informatics; 2009 Oct 17-19: Tianjin (China). doi:10.1109/BMEI.2009.5305423
   Google Scholar
• Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K, et al. Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 2005;11:1219–1225.
   PubMed Web of Science ®Google Scholar
• Hoffmann AC, Kaifi JT, Vallbohmer D, Yekebas E, Grimminger P, Leers JM, et al. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. J Surg Oncol 2009;100:414–417.
   PubMed Web of Science ®Google Scholar
• Haroun RA, Zakhary NI, Mohamed MR, Abdelrahman AM, Kandil EI, Shalaby KA. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1, and p16 in non-small cell lung cancer in Egyptian patients. Asian Pac J Cancer Prev 2014;15:4281–4287.
   PubMed Web of Science ®Google Scholar
• Vaissière T, Hung RJ, Zaridze D, Moukeria A, Cuenin C, Fasolo V, et al. Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors. Cancer Res 2009;69:243–252.
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338–3344.
   PubMed Web of Science ®Google Scholar
• Hiltunen MO, Alhonen L, Koistinaho J, Myöhänen S, Pääkkönen M, Marin S, et al. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 1997;70:644–648.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, et al. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J. Natl. Cancer Inst 2000;92:1805–1811.
   PubMed Web of Science ®Google Scholar
• Eguichi K, Kanai K, Hirohasi S. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res 1997;57:4913–4915.
   PubMed Web of Science ®Google Scholar
• Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP, et al. Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancers 2011;117:618–624.
   Web of Science ®Google Scholar
• Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med 2007;176:285–290.
   PubMed Web of Science ®Google Scholar
• Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Tatsumi K. Chronic obstructive pulmonary disease as a risk factor for lung cancer. World J Clin Oncol 2014;5:660–666.
   PubMedGoogle Scholar